Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intermittent Theta Burst Stimulation (iTBS) as a Treatment for Alcohol Use Disorder in Inpatient Treatment

NCT06696365 is registered in ClinicalTrials.gov with Nicholas Balderston, PhD as lead sponsor.

NCT NCT06696365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06696365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intermittent Theta Burst Stimulation (iTBS) as a Treatment for Alcohol Use Disorder in Inpatient Treatment
Lead sponsor
Nicholas Balderston, PhD
Phase
Not applicable
Overall status
Terminated
Start date
July 18, 2025
Completion date
April 8, 2026
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder (aud)